Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia

Simple item page
dc.contributor.authorKirsten R. Palmer
dc.contributor.authorTu’uhevaha J. Kaitu’u‐Lino
dc.contributor.authorPing Cannon
dc.contributor.authorLaura Tuohey
dc.contributor.authorManarangi S. De Silva
dc.contributor.authorManuel Varas‐Godoy
dc.contributor.authorStephanie Maia Acuña
dc.contributor.authorJosé Galaz
dc.contributor.authorStephen Tong
dc.contributor.authorSebastián E. Illanes
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:37:46Z
dc.date.available2026-03-22T14:37:46Z
dc.date.issued2016
dc.descriptionCitaciones: 15
dc.description.abstractPlasma sFLT-1 e15a is significantly increased in early-onset preeclampsia and term fetal growth restriction. Further assessment of the benefit for sFLT-1 e15a testing in prediction or diagnosis of these disease states is warranted.
dc.identifier.doi10.1080/14767058.2016.1182975
dc.identifier.urihttps://doi.org/10.1080/14767058.2016.1182975
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/47625
dc.language.isoen
dc.publisherInforma
dc.relation.ispartofThe Journal of Maternal-Fetal & Neonatal Medicine
dc.sourceMercy Hospital for Women
dc.subjectPreeclampsia
dc.subjectProspective cohort study
dc.subjectFetus
dc.subjectMedicine
dc.subjectCohort
dc.subjectBiomarker
dc.subjectFetal growth
dc.subjectIntrauterine growth restriction
dc.subjectPregnancy
dc.subjectObstetrics
dc.titleMaternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia
dc.typearticle

Files

Collections

Artículo Científico Publicado